5-hydroxymethylcytosine has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Han, H; Hou, Y; Jia, Y; Jiang, T; Li, S; Zhang, J; Zhang, L; Zhang, W; Zhao, C; Zheng, X; Zhou, L; Zong, L | 1 |
| Banerjee, M; Nair, C; Nair, IV; Saradalekshmi, KR; Swathy, B | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Schizophrenia
| Article | Year |
|---|---|
Variation in global DNA hydroxymethylation with age associated with schizophrenia.
Topics: 5-Methylcytosine; Adult; Age Factors; Case-Control Studies; DNA; DNA Methylation; Female; Humans; Male; Schizophrenia; Sex Factors | 2017 |
Understanding the influence of antipsychotic drugs on global methylation events and its relevance in treatment response.
Topics: 5-Methylcytosine; Adult; Antipsychotic Agents; Case-Control Studies; Clozapine; Cytosine; DNA; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Female; Haloperidol; Hep G2 Cells; Humans; Male; MicroRNAs; Olanzapine; Pharmacogenetics; Schizophrenia; Treatment Outcome | 2018 |